Open iTunes to buy and download apps.
Tap into the most recent developments in all aspects of clinical neurosurgery with the Acta Neurochirurgica app. Acta Neurochirurgica is a peer-reviewed medical journal published by Springer Science+Business Media that publishes papers dealing with clinical neurosurgery - diagnosis and diagnostic techniques, operative surgery and results, postoperative treatment - or with research work in neuroscience where underlying questions or results are of neurosurgical interest. The Journal continuously publishes review articles, original papers and educational articles written by leading members of the medical community. In addition to the regular journal, Acta Neurochirurgica publishes 3-4 supplement volumes per year. These comprise proceedings of international meetings or other material of general neurosurgical interest.
This free app provides valuable features including:
- Save and share articles
- Advanced search
- Document details - including abstracts
Acta Neurochirurgica is the official journal of the European Association of Neurosurgical Societies (EANS). The European Association of Neurosurgical Societies is a non-profit independent association of both neurosurgical societies and, increasingly importantly, individual members. The EANS has long been recognised for the scientific quality of the congresses, meetings and symposia which it organises, which include the four-yearly European Congresses of Neurosurgery, the Annual EANS meetings (formerly known as the Winter Meetings) and the European Neurosurgical Training Courses. EANS is committed to providing a forum to share and develop neurosurgical knowledge and also arranges a number of fellowship programmes and has an active Young Neurosurgeons section which arranges its own events.
- Category: Reference
- Released: Feb 19, 2014
- Version: 3.01
- Size: 7.4 MB
- Language: English
- Seller: Springer Science and Business Media, LLC
- © 2013 Springer Science+Business Media
Compatibility: Requires iOS 5.0 or later. Compatible with iPhone, iPad, and iPod touch. This app is optimized for iPhone 5.